Moleculin Announces Grant Funded Research Evaluating Annamycin for the Treatment of Pancreatic Cancer at UNC-Chapel Hill
Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia "MIRACLE" Clinical Trial at the 14th Annual Acute Leukemia Meeting
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
Sitka Drills 119.0 Metres of 1.01 g/t Gold from Surface, Including 10.7 Metres of 4.10 g/t Gold and 1.2 Metres of 24.8 g/t Gold, at the Contact Zone, Confirming Another near Surface Higher-Grade Gold Zone at Its RC Gold Project, Yukon
